3H (Shanghai) Pharmaceuticals

3H (Shanghai) Pharmaceuticals, widely known as 3H Management, is a leading clinical research organization (CRO) and site management organization (SMO) headquartered in Shanghai, China. Established in 2005, the company specializes in providing comprehensive clinical trial services, including site identification, patient recruitment, and clinical monitoring across a broad range of therapeutic areas. In 2014, 3H Management was acquired by PPD (Pharmaceutical Product Development) to bolster its presence and capabilities in the Chinese clinical research market. Today, as part of Thermo Fisher Scientific's clinical research business, 3H continues to support global and domestic pharmaceutical companies in conducting high-quality clinical trials in China.